Table 3. Meta-analysis of HIV prevalence in trans masculine individuals compared to all adults (age 15+).
| Country | Year of data collection | Number of samples | Sample size | Frequency of HIV among TM in the samples | Prevalence (95% CI)* | Odds Ratio (95% CI) | HIV prevalence in adults (95% CI) |
|---|---|---|---|---|---|---|---|
| Australia | 2004 | 1 | 17 | 0 | 0.0 (0.0–0.2) | 28.3 (1.7–470.5) | 0.101 (0.099–0.102) |
| Australia | 2012 | 1 | 28 | 1 | 3.6 (-3.3–10.4) | 29.4 (4–216.5) | 0.126 (0.124–0.127) |
| Brazil | 2002 | 1 | 16 | 0 | 0.0 (0.0–0.2) | 9.7 (0.6–160.9) | 0.313 (0.312–0.314) |
| Brazil | 2006 | 1 | 51 | 0 | 0.0 (0.0–0.1) | 2.6 (0.2–42.1) | 0.372 (0.371–0.373) |
| Canada | 2013 | 1 | 11 | 0 | 0.0 (0.0–0.3) | 19.1 (1.1–323.8) | 0.227 (0.226–0.229) |
| Italy | 2007 | 1 | 20 | 0 | 0.0 (0.0–0.2) | 11.6 (0.7–191.9) | 0.210 (0.208–0.211) |
| Italy | 2009 | 1 | 27 | 0 | 0.0 (0.0–0.1) | 8.6 (0.5–140.9) | 0.211 (0.210–0.212) |
| Spain | 2008 | 1 | 92 | 2 | 2.2 (-0.8–5.2) | 6.7 (1.6–27.1) | 0.332 (0.330–0.334) |
| US | 1997 | 1 | 123 | 2 | 1.6 (-0.6–3.9) | 5.9 (1.5–23.7) | 0.281 (0.280–0.282) |
| US | 2003 | 1 | 50 | 0 | 0.0 (0.0–0.1) | 3.0 (0.2–48.3) | 0.331 (0.330–0.332) |
| US | 2005 | 2 | 124 | 2 | 1.6 (-0.6–3.8) | 4.7 (1.2–19.2) | 0.345 (0.344–0.345) |
| US | 2007 | 2 | 92 | 8 | 8.7 (2.9–14.5) | 26.2 (12.7–54.2) | 0.362 (0.361–0.362) |
| US | 2009 | 2 | 292 | 2 | 0.7 (-0.3–1.6) | 1.8 (0.5–7.3) | 0.379 (0.378–0.379) |
| US | 2010 | 2 | 5256 | 21 | 0.4 (0.2–0.6) | 1.0 (0.7–1.6) | 0.387 (0.386–0.388) |
| US | 2011 | 1 | 120 | 10 | 8.3 (3.4–13.3) | 22.9 (12–43.8) | 0.395 (0.395–0.396) |
| US | 2012 | 1 | 30 | 1 | 3.3 (-3.1–9.8) | 8.7 (1.2–63.7) | 0.396 (0.395–0.396) |
| US | 2013 | 1 | 122 | 0 | 0.0 (0.0–2.8) | 1.0 (0.1–16.7) | 0.392 (0.391–0.393) |
| Overall | - | - | - | - | 2.56 (0.0–5.9)* | 6.8 (3.6–13.1) | - |
Note. Heterogeneity: Q = 13.06, df = 16, p<0.0001, I2 = 70.62%.
*Overall prevalence was calculated by direct standardization based on country-year weights used in meta-analysis.